Mike Klein
North America, Michigan, United States, Ann Arbor
Description
Mike Klein is CEO at Genomenon, Inc.
Investor Profile
Mike Klein has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Seed rounds (top funding stages).
- Majority of deals are located in United States.
- Strong thematic focus on Developer Tools, Enterprise Software, Genetics.
Stage Focus
- Seed (100%)
Country Focus
- United States (100%)
Industry Focus
- Developer Tools
- Enterprise Software
- Genetics
- Medical
- Software
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
